Importance of pacemaker noise reversion as a potential mechanism of pacemaker-ICD interactions

被引:10
作者
Glikson, M [1 ]
Trusty, JM [1 ]
Grice, SK [1 ]
Hayes, DL [1 ]
Hammill, SC [1 ]
Stanton, MS [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, Rochester, MN 55905 USA
来源
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 1998年 / 21卷 / 05期
关键词
pacemaker; implantable cardioverter defibrillator; noise reversion; asynchronous pacing;
D O I
10.1111/j.1540-8159.1998.tb00158.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Numerous types of interactions between pacemakers and implantable cardioverter defibrillators (ICDs) have been described. Pacemaker outputs preventing appropriate defection of ventricular tachycardia or ventricular fibrillation by the ICD is one of the more serious. Asynchronous pacemaker activity during ventricular arrhythmias map be caused by either nonsensing of the arrhythmia or by noise reversion, which is an algorithm that causes the pacemaker to switch to asynchronous pacing when repetitive sensing at a high rate occurs. We analyzed the mechanisms underlying asynchronous pacemaker activity in ventricular arrhythmias using pacemaker telemetry during the arrhythmia. Thirty-nine induced arrhythmias from 26 different procedures in 19 patients with both pacemakers and ICDs were analyzed. Of the 39 arrhythmias, asynchronous pacemaker activity occurred in 16. The underlying mechanism was nonsensing in 4 episodes and noise reversion in 12 episodes. Clinically significant interference with detection arose on three occasions. Conditions favoring the occurrence of noise reversion include specific pacemaker models, arrhythmia cycle lengths in the range causing noise reversion of the individual pacemaker model, long noise sampling periods, and VVI pacing mode. Noise reversion can be diagnosed by telemetering the pacemaker marker channel during ventricular arrhythmias as a part of routine pacemaker-ICD interaction evaluation. It can be prevented or minimized by programming short ventricular refractory periods or using pacemakers with short retriggerable refractory periods.
引用
收藏
页码:1111 / 1121
页数:11
相关论文
共 10 条
[1]   CLINICAL INTERACTIONS BETWEEN PACEMAKERS AND AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS [J].
CALKINS, H ;
BRINKER, J ;
VELTRI, EP ;
GUARNIERI, T ;
LEVINE, JH .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 16 (03) :666-673
[2]   SAFETY OF PACEMAKER IMPLANTATION IN PATIENTS WITH TRANSVENOUS (NONTHORACOTOMY) IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS [J].
CLEMO, HF ;
ELLENBOGEN, KA ;
BELZ, MK ;
WOOD, MA ;
STAMBLER, BS .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1994, 17 (12) :2285-2291
[3]  
DELNEGRO A, 1986, PACE, V9, P304
[4]   COMBINED AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR AND PACEMAKER SYSTEMS - IMPLANTATION TECHNIQUES AND FOLLOW-UP [J].
EPSTEIN, AE ;
KAY, GN ;
PLUMB, VJ ;
SHEPARD, RB ;
KIRKLIN, JK .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 13 (01) :121-131
[5]  
EPSTEIN AE, 1995, CLIN CARDIAC PACING, P757
[6]   NOISE REVERSION OF A DUAL CHAMBER PACEMAKER WITHOUT NOISE [J].
FROHLIG, G ;
DYCKMANS, J ;
DOENECKE, P ;
SEN, S ;
BETTE, L .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1986, 9 (05) :690-696
[7]  
LUCERI RM, 1991, NEW PERSPECTIVES CAR, V2, P527
[8]   IMPLANTED AUTOMATIC DEFIBRILLATORS - EFFECTS OF DRUGS AND PACEMAKERS [J].
SINGER, I ;
GUARNIERI, T ;
KUPERSMITH, J .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1988, 11 (12) :2250-2262
[9]  
Strathmore N., 1995, CLIN CARDIAC PACING, P770
[10]  
STROOBANDT R, 1992, FACE FACES CARDIAC P, P221